FDA tentatively OKs a pediatric dose of HIV drug abacavir sulfate - Related Stories - AAP SmartBrief
Links shared publicly online about this topic.
- 669total visits
FDA tentatively OKs a pediatric dose of HIV drug abacavir sulfate - Related Stories - AAP SmartBrief
Matrix Laboratories, a unit of Mylan, received tentative FDA approval for a 60-milligram tablet of abacavir sulfate to treat HIV-positive children. The approval was made under the President's Emergency Plan for AIDS Relief. <a href='/servlet/aaRedirect?url2=http%3a%2f%2fwww%2ebizjournals%2ecom%2fpit
View full resource at smartbrief.com
Tags: HIV, HIV Medication, STD, Drug, Children's Health, FDA, Ziagen
Most Recently Shared on December 8, 2010 at 11:27 pm By:
FDA tentatively OKs a pediatric dose of HIV drug abacavir sulfate http://sbne.ws/r/6gaX
Advertisement
